Friday 6 November 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024.

Revenue: +30.2%
EPS: −22.3%
Free cash flow: +137.8%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

300.31 0.06 +0.02%

Follow KRYS

Alert me

Market cap: $8.9B
P/E: 39.2×
Fwd P/E: 45.7×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	5	6	—	—	+8 more TTM periods Free account
ROE Full definition →	17.50%	20.12%	19.90%	18.91%
ROA Full definition →	15.93%	18.30%	18.21%	17.14%
ROIC Full definition →	27.15%	24.07%	24.64%	25.73%
Return on Tangible Assets Full definition →	19.89%	22.23%	21.12%	19.10%
Average Days of Receivables Full definition →	103.37	114.90	111.10	119.52
Free Cash Flow per Share Full definition →	10.47	8.73	8.11	6.54
Free Cash Flow Full definition →	310.08	257.78	237.38	189.35
Capital Expenditures Full definition →	(13.85)	(14.56)	(12.89)	(11.52)
Other line items
Cash ROIC Full definition →	13.21%	11.69%	11.30%	9.25%
Accounts Receivable Turnover Full definition →	3.58	3.52	3.62	3.35
Accounts Payable Turnover Full definition →	6.10	3.46	7.20	5.61
Inventory Turnover Full definition →	0.61	0.62	0.67	0.69
Average Days of Payables Full definition →	91.30	101.14	61.31	51.28
Days of Inventory on Hand Full definition →	688.89	704.10	639.41	640.96
Tax Rate Full definition →	(0.13)	0.07	0.09	0.08
Research and Development Expense of Revenue Full definition →	12.67%	13.45%	14.17%	14.92%
Selling, General and Administrative Expense of Revenue Full definition →	33.20%	36.30%	37.17%	37.71%
Share Based Compensation of Revenue Full definition →	11.80%	12.41%	13.09%	14.01%
Operating CF/Net income Full definition →	1.44	1.13	1.11	0.98
Depreciation/Fixed assets Full definition →	0.04	0.04	0.04	0.04
Capex/Depreciation Full definition →	(2.05)	(2.18)	(1.94)	(1.76)
Revenue per Share Full definition →	15.87	14.92	14.25	13.44
Operating CF per Share Full definition →	10.94	9.22	8.55	6.94
Capex per Share Full definition →	(0.47)	(0.49)	(0.44)	(0.40)
Capex to Sales Full definition →	0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly